financetom
Business
financetom
/
Business
/
--FAA to Continue Enhanced Oversight of Boeing Following 3-Hour Meeting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--FAA to Continue Enhanced Oversight of Boeing Following 3-Hour Meeting
May 30, 2024 12:17 PM

01:51 PM EDT, 05/30/2024 (MT Newswires) --

Price: 173.75, Change: +2.10, Percent Change: +1.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Workhorse Group Stock Monday?
What's Going On With Workhorse Group Stock Monday?
Jun 17, 2024
Workhorse Group Inc ( WKHS ) shares are in the spotlight Monday as the stock begins trading on a split-adjusted basis. Here’s a look at what you need to know. What To Know: Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company’s annual meeting of stockholders in May....
Vista Outdoor Says MNC Capital's Pressure Led to Withdrawal of Higher Bid for The Kinetic Group
Vista Outdoor Says MNC Capital's Pressure Led to Withdrawal of Higher Bid for The Kinetic Group
Jun 17, 2024
08:49 AM EDT, 06/17/2024 (MT Newswires) -- Vista Outdoor ( VSTO ) said Monday that a US investment firm's roughly $2.01 billion alternative acquisition proposal for The Kinetic Group has been withdrawn due to pressure from MNC Capital Partners. The sporting and outdoor products company said that MNC alleged that the alternate party violated prior contractual agreements made during a...
Johnson & Johnson Seeks US FDA Approval for Subcutaneous Amivantamab for Certain Patients With Non-Small Cell Lung Cancer
Johnson & Johnson Seeks US FDA Approval for Subcutaneous Amivantamab for Certain Patients With Non-Small Cell Lung Cancer
Jun 17, 2024
08:51 AM EDT, 06/17/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that it had submitted a Biologics License Application to the US Food and Drug Administration for subcutaneous amivantamab for certain patients with non-small cell lung cancer. The company said the application is based on a late-stage study that showed that the subcutaneous form was as...
Aerovate scraps late-stage study for hypertension drug after mid-stage trial fails
Aerovate scraps late-stage study for hypertension drug after mid-stage trial fails
Jun 17, 2024
June 17 (Reuters) - Aerovate Therapeutics ( AVTE ) said on Monday it is shutting down the late-stage portion of a study testing its experimental hypertension drug after failing to meet the main goal in a mid-stage trial. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved